Laboratory Results and Operations in WHO Phase 6 Dr. Attaporn Taweetungtragoon CYBELES Phnom Penh, Cambodia October 12-15, 2009.

Slides:



Advertisements
Similar presentations
FDA QS reg/CLIA Comparison: Overview
Advertisements

Setting up a Molecular Lab in a Developing Country
The Role of Laboratories in Surveillance Mahon 2006 Arnold Bosman Source: WHO-Lyon, Julia Fitzner, 2004.
The Roadmap to Successful Xpert Implementation - 37 steps -
The Laboratory Response Network
Introduction to Pandemic Influenza
Pediatric Diagnosis of HIV-1 Infection Using Dried Blood Spots Chin-Yih Ou, PhD NCHSTP/DHAP Centers for Disease Control and Prevention.
The Role of Mobile Medical Platforms in Pandemic Control & Treatment & Safe, Effective, Temperature Stable Diagnostic System ADAS Group.
Regional Health Focus Rome | 27 – 29 June |1 | Health Focus WHO Regional Perspective FAO/ OIE/ WHO Technical Meeting on Highly Pathogenic Avian.
U.S. Pandemic Influenza Preparedness and Response: Planning and Activities “The pandemic influenza clock is ticking. We just don’t know what time it is.”
Role of the laboratory in disease surveillance
DEPARTMENT OF HEALTH RESEARCH INSTITUTE FOR TROPICAL MEDICINE ROLES OF THE LABORATORIES IN EVD PREPAREDNESS Amado O. Tandoc III, MD, DPSP Department of.
Jay Hamm, RN, FACHE, COO/Acute Care Executive Steve Shelton, MD, Medical Director EM Eric Brown, MD, Physician Executive.
Laboratory Management - 1
Melissa House, Ph.D.: Public Health Walden University PUBH Instructor: Dr. Robert Marino Spring Qtr, 2011 D ISASTER P REPAREDNESS P ANDEMIC I NFLUENZA.
Laboratory Training for Field Epidemiologists Polymerase Chain Reaction Investigation strategies and methods May 2007.
The Quality Management System
Laboratory Training for Field Epidemiologists Strengthening Laboratory and Epidemiology Collaboration Introduction May 2007.
Laboratory Training for Field Epidemiologists Viral cultures Investigation strategies and methods May 2007.
WHO guidelines for investigation and control of Foodborne Diseases outbreak Dr. Christina Rundi Ministry of Health, Malaysia.
Martha Thompson, MPH Viral Isolation Team Leader Medical Virology Group Laboratory Services Section TX DSHS Influenza Surveillance Viral Isolation Laboratory.
Progress Report Global Pandemic Preparedness Beijing Conference January 2006 Dr Margaret Chan Assistant Director-General Communicable Diseases Representative.
PANDEMIC RISK. 3 pre-requisites for a Pandemic 1. The emergence of a new virus strain with no circulating immunity within the human population 2. The.
(CAREC) PAHO/WHO Serving 21 Member Countries in the English and Dutch Speaking Caribbean Preparations for the Next Pandemic (or Epidemic or Outbreak) Leslie.
Module 5: Assuring the Quality of HIV Rapid Testing
Laboratory Assessment Tool-LAT Philippe Dubois April 2-12, 2013 Phom Penh, Cambodia.
1 Module ON-SITE SUPERVISION OVERVIEW. 2 Content Overview What is on-site supervision? Advantages and disadvantages of on-site supervision Organization.
WORK TO BE DONE. Time line March-May 2013-Preparation June 2013-November Data collection December 2014-February Analysis and report preparation.
Pandemic Responses & activities Sri Lanka. Activities initiated in Sri Lanka A Fact sheet (English pdf),(Sinhala pdf) has been prepared and distributed.
1 WHO Communicable Diseases, Surveillance & Response SARS Diagnostics and Laboratory Needs: the WHO Perspective C.E. Roth Dangerous and New Pathogens Global.
Monitoring, supervision and quality control IDSP training module for state and district surveillance officers Module 11.
1 OIE Response to the HPAI Threat in the SADC Region 1 st SADC Meeting on Avian Influenza Pretoria, South Africa 7-9 March 2006 Sub Regional Representation.
First National Course on Public Health Emergency Management 12 – 23 March Muscat, Oman.
Text WHO Global Influenza Programme NIC Role during a pandemic and NIC contingency plan Wenqing Zhang MD Global Influenza Programme, WHO HQ THE 3rd MEETING.
World Health Organization, Regional Office for The Western Pacific Regional Activities Report and Preparation for the Upcoming Influenza Seasons THE 3rd.
P1 External Quality Assessment (EQA) Proficiency Testing.
Laboratory Integration in Influenza Surveillance Dr Geethani Wickramasinghe NIC- Sri Lanka.
ASDPE Asia Pacific Strategy for Emerging Diseases (2010) and Influenza Activities Health Security and Emergencies (DSE) WHO Western Pacific Regional Office.
Result of gap analysis and framework of action required in coming five months August rd Meeting of National Influenza Centres in the Western.
Pandemic Response and Activities: Bangladesh Mr. Barun Dev Mittra, Additional Secretary, Ministry of Health and Family Welfare Dr. M Mushtuq Husain, PhD.
The WHO HIV Drug Resistance Strategy Presented by Dr. Don Sutherland Prepared by: Dr. Don Sutherland Dr Silvia Bertagnolio Dr Diane Bennett HIV Drug Resistance.
Communicable Disease Surveillance and Response, WHO Avian Influenza Credit: WHO Viet Nam.
TM Emerging Health Threats and Health Information Systems: Getting Public Health and Clinical Medicine to Real Time Response John W. Loonsk, M.D. Associate.
David Featherstone EPI / IVB WHO/HQ Measles Partners Meeting September 2008 Washington Global Measles Rubella Laboratory Network: Update.
Global capacities, alert and response Improving laboratory quality to aid the control of dengue Meeting of the WHO Collaborating Centres for detection.
Training structure Safety and good quality work Module 1: Knowledge about Ebola Virus Disease Support from the community Support from the hospital.
Laboratory Response to the 2009 H1N1 Event Texas Department of State Health Services Laboratory Services Section Grace Kubin, Ph.D. Vanessa Telles, MPH.
Conclusions 3 rd Meeting of National Influenza Centres in the Western Pacific and South East Asia Regions 18 – 20 August 2009 Beijing, China.
Impact of Early Infant Diagnostic (EID) Testing for HIV Exposed Infants in Namibia Dr. Ndapewa Hamunime (MOHSS) Dr. Andreas Shiningavamwe (NIP) Republic.
Exposure Rostering: Population Tracking Following a Disaster Melissa E. Powell, MPH Michelle F. Barber, MS Preparedness, Surveillance & Epidemiology PUBLIC.
Wrap-up Day 2. Plenary Four: Pandemic and avian influenza updates Pandemic H1N1 – Origin of pandemic H1N1 virus – Genetically and antigenically homogenous.
(CAREC) PAHO/WHO Serving 21 Member Countries in the English and Dutch Speaking Caribbean 2009 Pandemic Influenza in CAREC Member Countries: Summary and.
TM Coordinating the Functions, Uses and Activities of Systems and Organizations Involved in Public Health Surveillance John W. Loonsk, M.D. Director Information.
National Influenza Centres in SEA Region Dr Rajesh Bhatia / Dr Oommen John WHO Regional Office for South-East Asia New Delhi 5 th Meeting of NIC in Western.
Ebola preparedness and Response in Lao PDR. Outline Objective The preparedness contingency plan Phase 1: Preparedness Phase 2: Contingency for response.
ASDPE Regional Plan for Strengthening the National Influenza Surveillance Capacity: Guiding the way towards a comprehensive National Influenza Surveillance.
Influenza Pandemic Preparedness and Response Ministry of Health, National Centre for Communicable Diseases, Mongolia 1.
Session 6: Data Flow, Data Management, and Data Quality.
Clinical Utility of EQA Dr. Angela Amayo UON27/11/2008.
Overview of Quality Assurance
Training structure EFFO Ebola Safety and good quality work
Investigation strategies and methods
Cedric Lazarus Livestock Development Officer
Role of the Military during disease outbreaks
The Role of NICs in Influenza Surveillance
Planning for Pandemic Influenza
Progress of OIE Regional AI Programme in Southeast Asia
Workshop on the Revised WHO Guidance
Samia Metwally, DVM, PhD (FAO)
Presentation transcript:

Laboratory Results and Operations in WHO Phase 6 Dr. Attaporn Taweetungtragoon CYBELES Phnom Penh, Cambodia October 12-15, 2009

Background  The Protocols are based on Detection, Investigation, and Reporting  Rapid Response and Containment  The strategy is geographically based  Containment and Buffer zone operations include Surveillance and on going laboratory testing Surveillance and on going laboratory testing Containment communications Containment communications Antiviral administration Antiviral administration

Containment/Buffer Zone Checklist  Identification of Laboratories  Field Response Teams  Sample Collection  Specimen testing and reporting  Specimen shipping  Specimen storage  Logistical support

Early Detection and Rapid response  Reliable Laboratory testing can provide resource focus, disease patterns, and patient contact/education  Buffer zone testing is also indicated as part of the Surveillance program  Buffer zone lab testing will continue as long as the containment is on going  Containment and Buffer Zone key tasks --Extensive antiviral prophylaxis and treatment -- Surveillance and LABORATORY --Extensive antiviral prophylaxis and treatment -- Surveillance and LABORATORY TESTING TESTING --Assessment of the novel virus --Assessment of the novel virus

What do we need for setting up PCR/ qRT-PCR lab for Flu tests Instruments Supplies Cold reagents Room temperature supplies Well trained lab staffs

Illustrated PCR Workflow Prepare the RNA template Extraction of Nucleic Acid (RNA/DNA) Prepare the RT-PCR reactions Run the experiment Design and set up PCR experiment Amplification plot Interpretation of the result Manual RNA extraction Automatic extraction System Software

RNA /DNA Extraction Systems Small Scale Extraction System (8 samples/run) Big Scale Extraction System (96 samples/run)

Variety of PCR and Real-Time RT-PCR Instruments Small scale laboratory InstrumentPCR Big scale laboratory instrument Real-Time PCR SENSOQUEST

Real-Time RT-PCR System Software

Interpretation of Results Target Pathogen Internal control Negative control Positive control Interpretation POS NEGPOS NEGPOSNEGPOSNEG INVALID POS INVALID

Sample collection methods are poor Sample collection methods are poor Lack of refrigeration in shipping and storage process Lack of refrigeration in shipping and storage process RT-PCR testing done incorrectly RT-PCR testing done incorrectly Positive results are not identified Positive results are not identified Results are not reported in a timely manner Results are not reported in a timely manner Results are not numbered and stored correctly Results are not numbered and stored correctly Leaders do not understand the meaning of the results because they are not displayed correctly Leaders do not understand the meaning of the results because they are not displayed correctly The results are not acted in time because the leaders do not understand how important the results are. The results are not acted in time because the leaders do not understand how important the results are. What can go wrong with Laboratory results?

WHO Laboratory Confirmation Laboratory in Cambodia Laboratory in Cambodia The WHO Representative in Cambodia No corner Streets Pasteur (51) and 254 PO Box 1217 Phnom Penh Cambodia The WHO Representative in Cambodia No corner Streets Pasteur (51) and 254 PO Box 1217 Phnom Penh Cambodia Laboratory in Thailand Laboratory in Thailand The WHO Representative Soi Bamrasnaradoon, Permanent Secretary Building 3, 4th Floor Tiwanond Road Nonthaburi The WHO Representative Soi Bamrasnaradoon, Permanent Secretary Building 3, 4th Floor Tiwanond Road Nonthaburi Thailand Laboratory in Japan Laboratory in Japan WHO Technology Transfer Programme Office c/o International Medical Centre of Japan Toyama, Shinjuku-ku Tokyo JAPAN WHO Technology Transfer Programme Office c/o International Medical Centre of Japan Toyama, Shinjuku-ku Tokyo JAPAN Host Nation Laboratory that is Ministry of Health operated Host Nation Laboratory that is Ministry of Health operated

Laboratory Testing and preparedness  Testing all suspected cases is preferred but may not be possible  Potential large numbers will be tested if Containment operations are initiated requiring local, state and federal coordination  Equipment and consumable supply requirements  WHO collaborating centers and other reference Labs will perform molecular and genetic studies

National Pandemic planning for Laboratory operations Identify all Laboratories in the country and list their capabilities Identify all Laboratories in the country and list their capabilities Identify Labs that can perform Novel virus testing Identify Labs that can perform Novel virus testing Test all Laboratory proficiencies annually with WHO Test all Laboratory proficiencies annually with WHO Work with WHO as a regional partner Work with WHO as a regional partner

Laboratory Field Response Teams Establish fast response Laboratory teams (May include military component) Establish fast response Laboratory teams (May include military component) Must have vaccinations, passports Must have vaccinations, passports Team members must have training in influenza diagnostics, safe specimen handling, and dangerous goods packaging & shipping Team members must have training in influenza diagnostics, safe specimen handling, and dangerous goods packaging & shipping National authorities must stockpile adequate PPE, specimen collection and transportation materials, and swabs. National authorities must stockpile adequate PPE, specimen collection and transportation materials, and swabs.

Specimen Collection, Shipping, Reporting, & Storage Develop a consistent and systematic method to label specimens that links them to patients and epidemiological data. Develop a consistent and systematic method to label specimens that links them to patients and epidemiological data. Ensure import and export documents are in place in advance. Ensure import and export documents are in place in advance. Determine which staff can interpret and report the results. Determine which staff can interpret and report the results. Develop a plan & capacity for storing representative specimens, isolates, and nucleic extracts for research and evaluating mutations Develop a plan & capacity for storing representative specimens, isolates, and nucleic extracts for research and evaluating mutations

Summary  Laboratory testing is on going from pre pandemic to recovery  Supplies and equipment must be utilized in training activities  Field and in-house Lab testing is a critical component of Containment and Buffer zone operations  Laboratory testing will determine effectiveness of operations and drive decision-making at all levels